- WKN: 593273
- ISIN: DE0005932735
- Land: Deutschland
Nachricht vom 05.08.2021 | 06:30
YOC AG: YOC AG with revenue growth of 40% in the second quarter of 2021 - VIS.X(R) trading platform as a driver of the company's progress
DGAP-News: YOC AG
/ Key word(s): Development of Sales
YOC AG with revenue growth of 40% in the second quarter of 2021 - VIS.X(R) trading platform as a driver of the company's progress
Berlin, August 05, 2021 - The ad tech company YOC AG (ISIN DE0005932735) reports a year-on-year revenue growth of around 40% to EUR 4.2 million (Q2/2020: EUR 3.0 million) for the past second quarter of 2021.
As a result, the company improved its earnings before interest, taxes, depreciation and amortization (EBITDA)* by around 35% to EUR 0.8 million (H1/2020: EUR 0.6 million) in the first half of 2021.
YOC AG will publish its report on the first half of 2021 as scheduled on August 18, 2021.
* EBITDA corresponds to the definition in YOC AG's report on the financial year 2020 (available at https://yoc.com/de/investor-relations-yoc/finanzen-geschaeftsbericht/)
YOC is a technology company and develops software for the digital advertising market. With the help of our programmatic trading platform VIS.X(R) we enable an optimal advertising experience for advertisers, publishers and users of the mobile internet and mobile applications. By using the platform VIS.X(R) and YOC's proprietary ad formats, advertisers can increase awareness for their brand or products in combination with high-quality advertising inventory. Renowned premium publishers offer global media reach and benefit from the high monetization of our platform VIS.X(R). As a pioneer in mobile advertising, the company has been operating since 2001 and has been listed in the Prime Standard of Deutsche Börse since 2009. The company's headquarters are located in Berlin. The company also operates branches in Düsseldorf, Hamburg, Vienna and Warsaw. Further information on the YOC Group and our products can be found at yoc.com.
|Greifswalder Str. 212|
|Phone:||+49 (0)30-72 61 62 322|
|Fax:||+49 (0)30-72 61 62 222|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1224030|
|End of News||DGAP News Service|
YOC AG: Nielsen Study demonstrates: YOC High-I ...
YOC AG: YOC AG with significant profit increas ...
YOC AG: VIS.X Direktintegration mit globaler E ...
YOC AG: YOC AG with revenue growth of around 2 ...
YOC AG: YOC AG integrates Oracle Contextual In ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
03. Dezember 16:37 Allianz: Kursziel 250 Euro
03. Dezember 16:48 Update DocuSign: Minus steigt auf 40 Prozent! Der nächste ...
03. Dezember 17:00 DAX: Der nächste Nackenschlag
03. Dezember 17:54 Börsenpunk: DAX - Angst ist zurück an den Märkten - jetzt trotzdem ...
03. Dezember 18:09 Alibaba, Tencent und Co: Kleiner Crash vorm Wochenende
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021